FIELD: medicine. SUBSTANCE: new inhalation composition for bronchial asthma treatment has medicinal agents used at bronchial asthma and sodium benzoate as diluent. Concentration of sodium benzoate in composition is from 20 to 99.8%. Proposed composition does not cause by-side effects (fungal disease in mouth cavity) that are taken place if sugars were used as diluents. EFFECT: enhanced effectiveness of composition. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIALLERGIC AND ANTI-IFLAMMATORY AGENT | 1999 |
|
RU2170091C2 |
ANTIALLERGENIC AND ANTIINFLAMMATORY AGENT | 1999 |
|
RU2160097C1 |
2-HYDROXY-3-METHOXYBENZALDEHYDE ISONICOTINOYL HYDRAZONE SHOWING ANTIASTHMATIC, ANTI-INFLAMMATORY AND ANTI-ALLERGIC ACTIVITY | 1997 |
|
RU2139711C1 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTIINFLAMMATORY, BRONCHOLYTIC, ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2448961C1 |
INHALATION COMPOSITION FOR TREATMENT OF BRONCHIAL ASTHMA | 2002 |
|
RU2242972C2 |
PREPARATION FOR TUBERCULOSIS TREATMENT | 1994 |
|
RU2080114C1 |
METHYL FOR SEPARATION OF 3-CHLORO-4,6-DICHLOROSULFONYLANILINE | 1990 |
|
RU1736145C |
DERIVATIVES OF 2-(3,4-DIHYDROXYPHENYL) ETHYLAMINE SHOWING IMMUNOTROPIC ACTIVITY AND CAPABILITY TO INHIBIT VIRUS REPLICATION | 1992 |
|
RU2039733C1 |
N-(2,4,6-TRIMETHYLPHENYLCARBAMOYLMETHYL)-N-ALLYLMORPHOLINIUM BROMIDE SHOWING ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS AT ISCHEMIC HEART DISEASE AND A METHOD OF ITS SYNTHESIS | 1997 |
|
RU2105554C1 |
MONO- OR DICARBOXYLIC ACID ZINC SALTS SHOWING GASTROPROTECING ACTIVITY | 1995 |
|
RU2116292C1 |
Authors
Dates
1996-02-27—Published
1992-06-26—Filed